Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin.
Lee JS, Han P, Chaudhury R, Khan S, Bickerton S, McHugh MD, Park HB, Siefert AL, Rea G, Carballido JM, Horwitz DA, Criscione J, Perica K, Samstein R, Ragheb R, Kim D, Fahmy TM.
Lee JS, et al.
Nat Biomed Eng. 2021 Sep;5(9):983-997. doi: 10.1038/s41551-021-00791-0. Epub 2021 Oct 6.
Nat Biomed Eng. 2021.
PMID: 34616050